Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immatics NV (IMTX)

Immatics NV (IMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immatics NV PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076 DEU

www.immatics.com P: 071-539-7700 F: 071-539-7900

Description:

Immatics N.V. engages in the discovery of targets for cancer immunotherapies. It is developing targeted immunotherapies with focus on treating solid tumors. Immatics N.V., formerly known as ARYA SCIENCES, is based in Tuebingen, Germany.

Key Statistics

Overview:

Market Capitalization, $K 1,017,589
Enterprise Value, $K 781,139
Shares Outstanding, K 84,658
Annual Sales, $ 58,440 K
Annual Net Income, $ -104,980 K
Last Quarter Sales, $ 32,860 K
Last Quarter Net Income, $ -3,320 K
EBIT, $ -96,350 K
EBITDA, $ -88,520 K
60-Month Beta 0.75
% of Institutional Shareholders 64.41%
Float, K 84,658
% Float 100.00%
Short Volume Ratio 0.41

Growth:

1-Year Return 4.16%
3-Year Return -2.59%
5-Year Return 18.66%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 05/14/24
Next Earnings Date 08/15/24
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Qtr 87.50%
EPS Growth vs. Prev Year 85.71%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.37%
Return-on-Assets % -15.95%
Profit Margin % -179.64%
Debt/Equity 0.00
Price/Sales 16.83
Price/Cash Flow N/A
Price/Book 2.26
Book Value/Share 5.14
Interest Coverage -12.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar